Back
PIMCO Corporate & Income Opportunity Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
43
PTY
PIMCO Corporate & Income Opportunity Fund
Last Price:
$12.79
Seasonality Move:
-0.47%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$42.83
Seasonality Move:
0.59%
Sell
43
PIMCO Corporate & Income Opportunity Fund (PTY)
is a Sell
Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?
-
The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $12.88. The Score for PTY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.81. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTY Stock Price Chart
What is PIMCO Corporate & Income Opportunity Fund's stock price today?
-
The PIMCO Corporate & Income Opportunity Fund share price today is $12.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTY is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.87 | Buy |
| Relative Strength Index (14 RSI): | 29.79 | Sell |
| Chaikin Money Flow: | -1059987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.9 - 13.22) | Sell |
| Bollinger Bands (100): | (13.31 - 14.35) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.79 | Buy |
| Relative Strength Index (14 RSI): | 61.76 | Buy |
| Chaikin Money Flow: | 156273 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.4 - 40.3) | Buy |
| Bollinger Bands (100): | (17.9 - 35) | Buy |
PTY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.9 | Sell |
| 20-day SMA: | 13.08 | Sell |
| 50-day SMA: | 13.42 | Sell |
| 200-day SMA: | 13.82 | Sell |
| 8-day EMA: | 8.17 | Buy |
| 20-day EMA: | 4.25 | Buy |
| 50-day EMA: | 1.91 | Buy |
| 200-day EMA: | 0.51 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.78 | Buy |
| 20-day SMA: | 38.2 | Buy |
| 50-day SMA: | 33.84 | Buy |
| 200-day SMA: | 18.39 | Buy |
| 8-day EMA: | 28.27 | Buy |
| 20-day EMA: | 15.3 | Buy |
| 50-day EMA: | 7 | Buy |
| 200-day EMA: | 1.88 | Buy |
PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
PIMCO Corporate & Income Opportunity Fund Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||